TFCP2L1 and cancer: We performed a subgroup analysis on CIS‐accompanying cases (Appendix Table S4) and observed a significant association between high co‐expression of p‐TFCP2L1 and CDK1 in the main tumor and frequent cancer‐specific death (P = 0.015).